Search

3i Group PLC

Slēgts

SektorsIndeksi

3,341 -0.92

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

3232

Max

3388

Galvenie mērījumi

By Trading Economics

Ienākumi

3B

Pārdošana

1.6B

P/E

Sektora vidējais

8.273

18.062

EPS

3.09

Dividenžu ienesīgums

1.74

Peļņas marža

188.169

Darbinieki

223

EBITDA

3B

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+40.08% upside

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

1.74%

8.03%

Nākamais dividenžu datums

2026. g. 9. janv.

Nākamais Ex dividenžu datums

2025. g. 27. nov.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

4.7B

44B

Iepriekšējā atvēršanas cena

3341.92

Iepriekšējā slēgšanas cena

3341

3i Group PLC Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 13. nov. 10:02 UTC

Peļņas
Galvenie tirgus virzītāji

3i Group Shares Tumble After Cautious Outlook

2025. g. 13. nov. 07:29 UTC

Peļņas

3i Group: First Div Is Set at 50% of Total Div for FY2025

2025. g. 13. nov. 07:29 UTC

Peļņas

3i Group PLC Declares Dividend of 36.5p

2025. g. 13. nov. 07:28 UTC

Peļņas

3i Group Had Net Debt of GBP772M, Gearing of 3%

2025. g. 13. nov. 07:28 UTC

Peļņas

3i Group Ended Period With Liquidity of GBP1.64B

2025. g. 13. nov. 07:26 UTC

Peļņas

3i Group: Several of Other Large Portfolio Companies Are Showing Good Momentum

2025. g. 13. nov. 07:25 UTC

Peļņas

3i Group: Action Continued to Trade Strongly

2025. g. 13. nov. 07:25 UTC

Peļņas

3i Group Private Equity Business Delivered a Gross Investment Return of GBP3.23B

2025. g. 13. nov. 07:25 UTC

Peļņas

3i Group Total Return GBP3.29B, or 13% on Opening Shareholders' Funds

2025. g. 13. nov. 07:12 UTC

Peļņas

3i Group: Action Generated Net Sales of EUR11.23B in Nine Reporting Periods Ending Sep. 28

2025. g. 13. nov. 07:07 UTC

Peļņas

3i Group Private Equity Business Gross Investment Return GBP3.23B

2025. g. 13. nov. 07:07 UTC

Peļņas

3i Group Had Liquidity of GBP1.64B at Sep. 30

2025. g. 13. nov. 07:07 UTC

Peļņas

3i Group Had Net Debt of GBP772M, Gearing of 3%

2025. g. 13. nov. 07:05 UTC

Peļņas

3i Group Raises Dividend to 36.5p Vs 30.5p

2025. g. 13. nov. 07:03 UTC

Peļņas

3i Group: Transaction Market and Wider Environment Likely to Remain Challenging Into Fiscal 2H

2025. g. 13. nov. 07:03 UTC

Peļņas

3i Group: Remain Cautious in Deployment of Capital Into New Investment, Will Continue to Allocate Selectively

2025. g. 13. nov. 07:02 UTC

Peļņas

3i Group 1H NAV/Shr 2,857p

2025. g. 13. nov. 07:02 UTC

Peļņas

3i Group Total Return GBP3.29B

2025. g. 13. nov. 07:00 UTC

Peļņas

3i 1H EPS GBP3.398

2025. g. 13. nov. 07:00 UTC

Peļņas

3i 1H NAV/Shr GBP28.57

2025. g. 2. sept. 11:16 UTC

Tirgus saruna

3i Group Seems to Value Investments Conservatively -- Market Talk

2025. g. 2. sept. 06:40 UTC

Iegādes, apvienošanās, pārņemšana

3i Group: Price is 30% Premium to MAIT's March 31 Valuation

2025. g. 2. sept. 06:39 UTC

Iegādes, apvienošanās, pārņemšana

3i Group Selling MAIT for GBP143M

2025. g. 2. sept. 06:38 UTC

Iegādes, apvienošanās, pārņemšana

3i Group: DBAG is a Private Equity Fund Advised by Deutsche Beteiligungs

2025. g. 2. sept. 06:38 UTC

Iegādes, apvienošanās, pārņemšana

3i Group: MAIT is IT Services Provider for Mid-Market Customers in DACH Region

2025. g. 2. sept. 06:38 UTC

Iegādes, apvienošanās, pārņemšana

3i Group to Sell MAIT to DBAG

2025. g. 24. jūl. 06:09 UTC

Peļņas

3i Group: Focus on Actively Managing Portfolio, Remain Cautious on Pricing for New Investment

2025. g. 24. jūl. 06:09 UTC

Peļņas

3i Group: Resilient Performance from Majority of Remaining Private Equity Portfolio

2025. g. 24. jūl. 06:09 UTC

Peļņas

3i Group 1Q Foreign Exchange Translation Gain GBP392M

2025. g. 24. jūl. 06:04 UTC

Peļņas

3i Group YTD Operating EBITDA GBP980M

3i Group PLC Prognoze

Cenas mērķis

By TipRanks

40.08% augšup

Prognoze 12 mēnešiem

Vidējais 4,706.67 GBX  40.08%

Augstākais 5,200 GBX

Zemākais 4,100 GBX

Pamatojoties uz 7 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi 3i Group PLC — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

7 ratings

5

Pirkt

2

Turēt

0

Pārdot

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par 3i Group PLC

3i Group plc is a private equity firm specializing in mature companies, growth capital, middle markets, infrastructure, and management leveraged buyouts and buy-ins. The firm also provides infrastructure financing and debt management. For debt management, it invests in senior and mezzanine corporate debt in typically large and private companies in United Kingdom, Europe, Asia, and North America. It makes private equity investments in business and technology services, financial services, consumer, healthcare, consumption and distribution, media and telecom, renewable energy, wind, and industrial technology sector. Within business and technology services, the firm seeks to invest in sub sectors such as testing, inspection and certification; intelligent outsourcing, BPO and consultancy; human capital including staffing, governance, risk and compliance, services to pharmaceutical companies, vertical application software, education and training businesses; facilities management; support services to industrial sectors such as oil and gas and utilities; human resources outsourcing and advising; recruitment; logistics and infrastructure support services including distribution, waste, and rental. In the consumer sector, it focuses on, multi-unit roll out, omni-channel propositions, niche branded consumer goods, polarization, health and wellness, ageing population, millennials, consumer goods; e-commerce; retail; food and drinks; and leisure. In the healthcare sector, the firm focuses on outsourced medical device manufacturing & services, outsourced pharmaceutical manufacturing & services, bioprocessing supply chain, life science tools and diagnostics, wellness & consumer health products, pharmaceuticals and biotechnology including specialty pharma, generics / OTC, drug delivery, and animal health; healthcare Services including activities such as elderly and specialty care, including caring for people in their own homes, in hospital and in community facilities, as well as operational services such as outsourced support, cl
help-icon Live chat